Compare

IP Strategy Holdings, Inc. vs Buda Juice, Inc. vs SRX Global Inc. vs Arcadia Biosciences, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearIP Strategy Holdings, Inc.
IPST
Buda Juice, Inc.
BUDA
SRX Global Inc.
SRXH
Arcadia Biosciences, Inc.
RKDA
Year ended2025-12-312025-12-312025-09-302025-12-31
Revenue$10.12M$12.61M$6.53M$4.86M
Revenue growth (YoY)+20.4%+11.8%n/a-3.7%
Gross margin54.9%44.6%23.4%36.2% (computed)
Operating marginn/m27.4%-174.6%-51.5%
Net marginn/m28.0%-688.8%-48.1%
Net income-$137.72M$3.53M-$45.01M-$2.34M
EPS (Diluted)-$16.03$0.20-$2.13-$1.71
Operating cash flow-$15.33M$3.15M-$8.14M-$4.74M
Free cash flow-$15.40M$2.90Mn/a-$4.74M
Cash & equivalentsn/an/a$1.31M$259.0K
Total assets$108.76M$4.97M$8.40M$6.55M
Total liabilities$10.54M$1.23M$8.00M$2.41M
Shareholders' equity$98.22M$3.74M$407.0K$4.14M
Return on year-end equity-140.2%94.5%n/m-56.5%
Shares outstanding9.65Mn/a24.92M1.37M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearIP Strategy Holdings, Inc.Buda Juice, Inc.SRX Global Inc.Arcadia Biosciences, Inc.
Latest$10.12M
Ended 2025-12-31
$12.61M
Ended 2025-12-31
$6.53M
Ended 2025-09-30
$4.86M
Ended 2025-12-31
1 year earlier$8.40M
Ended 2024-12-31
$11.27M
Ended 2024-12-31
n/a$5.04M
Ended 2024-12-31
2 years earlier$7.97M
Ended 2023-12-31
n/an/a$4.45M
Ended 2023-12-31
3 years earliern/an/an/a$7.42M
Ended 2022-12-31
4 years earliern/an/an/a$6.78M
Ended 2021-12-31